Summary: 

This special issue on Emerging 3D Bioprinting Strategies for Advanced Tissue and Cancer Models explores cutting-edge 3D bioprinting techniques to create sophisticated tissue engineering constructs and cancer models that mimic human physiology more accurately than traditional 2D approaches.

Key Focus Areas

• Innovative bioprinting methods, including multi-material extrusion, laser-induced printing, and scaffold-free assembly for complex organoids and tumor microenvironments.
• Emerging biomaterials and bioinks tailored for cell viability, vascularization, mechanical properties, and ethical non-animal models in advanced tissue engineering.
• Cancer-specific applications like patient-derived tumor models for drug screening, metastasis studies, and personalized therapy validation.

Expected Impact

Papers will highlight translational potential, from in vitro disease modeling to preclinical testing, bridging bioprinting advances with clinical oncology needs. Submissions are encouraged on interdisciplinary strategies integrating AI, microfluidics, and stem cells.